Lijun Ou Selected Research

Apolipoproteins

1/2019

Xiaoyaosan prevents atherosclerotic vulnerable plaque formation through heat shock protein/glucocorticoid receptor axis-mediated mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijun Ou Research Topics

Disease

3	Angina Pectoris 12/2019 - 08/2018
2	Stable Angina 12/2019 - 08/2018
1	Depressive Disorder (Melancholia) 11/2020
1	Body Weight (Weight, Body) 11/2020
1	Disease Resistance 01/2019
1	Atherosclerosis 01/2019
1	Coronary Disease (Coronary Heart Disease) 08/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017

Drug/Important Bio-Agent (IBA)

2	gualou xiebai baijiutangIBA 12/2019 - 08/2018
2	gualou xiebai banxia decoctionIBA 12/2019 - 08/2018
2	Nitroglycerin (Dynamite)FDA LinkGeneric 11/2018 - 08/2018
1	xiaoyaosanIBA 11/2020
1	CorticosteroneIBA 11/2020
1	LipidsIBA 12/2019
1	Formate DehydrogenasesIBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2019
1	C-Reactive ProteinIBA 01/2017
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017

Therapy/Procedure

1	Therapeutics 11/2020